The 1980s bad blood scandal in Australia is a deeply troubling chapter in the country's medical history. It involves the contamination of blood products with hepatitis C and HIV, affecting thousands of people, including children. This scandal raises important questions about the safety of blood supplies and the responsibility of medical institutions. The story is particularly poignant for those like Tristan Stanley, Tony David, Niel Lake, and Lyn Hatch, who have suffered long-term health consequences and emotional trauma due to the contaminated blood they received. The scandal also highlights the need for better donor screening and testing practices, as well as the importance of accountability and compensation for victims.
The contaminated blood scandal was a global issue, but Australia's response has been criticized for its lack of comprehensive action. A 2004 Senate inquiry found that the government's handling of the crisis was inadequate, and that financial compensation was not in the best interests of those infected. The Red Cross, a key player in the blood banking system, faced scrutiny for its donor screening practices, particularly its failure to exclude high-risk groups and the introduction of surrogate testing. Despite the Senate inquiry's findings, the Red Cross and other institutions did not admit liability, and the federal and state governments were forced to settle compensation claims.
The haemophilia community, which was disproportionately affected by the contaminated blood, has struggled to access compensation. Most were infected with hepatitis C, and many have been unable to identify the exact donor that infected them, making them ineligible for existing state compensation schemes. The Haemophilia Foundation of Australia has been advocating for a dedicated financial scheme, but discussions with the current government are ongoing.
The scandal also raises questions about the safety of blood products and the responsibility of medical institutions. Cabinet minutes from 1985 and 1988 detail the urgent need to upgrade the Commonwealth Serum Laboratories' blood fractionation facility, which was found to be non-compliant with Good Manufacturing Practice standards. Despite these warnings, the facility continued to operate, and the government was aware of the potential risks. The privatization of CSL Limited in 1994 and the indemnification of its new owners against claims further complicated the situation.
The UK's Infected Blood Inquiry, which delivered a damning report in 2024, has given hope to Australian survivors. The inquiry found that many infections were preventable and established a broad-brush compensation scheme. Tristan Stanley, Tony David, and Niel Lake, along with a key lawyer involved in the UK inquiry, have presented their case to politicians in Canberra, receiving support from members of each major political party. The Australian government's response to the scandal remains an 'unfinished business', and the survivors are determined to keep fighting for justice.
